FDA Inspection 1259652 — Aspire Fertility Institute Dallas
The FDA completed an inspection of Aspire Fertility Institute Dallas on January 23, 2025 in Addison, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 23, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Addison, TX (United States)